1. Home
  2. AGMH vs ISPC Comparison

AGMH vs ISPC Comparison

Compare AGMH & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGM Group Holdings Inc.

AGMH

AGM Group Holdings Inc.

SELL

Current Price

$0.35

Market Cap

1.4M

Sector

Technology

ML Signal

SELL

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

HOLD

Current Price

$0.48

Market Cap

1.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGMH
ISPC
Founded
2015
2009
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.5M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
AGMH
ISPC
Price
$0.35
$0.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 150.9K
97.3K
Earning Date
12-01-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.03
EPS
★ N/A
N/A
Revenue
N/A
★ $1,928,998.00
Revenue This Year
N/A
$638.10
Revenue Next Year
N/A
$17.50
P/E Ratio
$0.07
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.34
$0.47
52 Week High
$3.62
$115.00

Technical Indicators

Market Signals
Indicator
AGMH
ISPC
Relative Strength Index (RSI) 28.41 16.01
Support Level $0.34 N/A
Resistance Level $1.42 $0.96
Average True Range (ATR) 0.05 0.08
MACD -0.00 -0.01
Stochastic Oscillator 2.69 3.70

Price Performance

Historical Comparison
AGMH
ISPC

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is a technology company engaged in technology hardware research and development, manufacturing, assembly, and sales. Its core business segments include research and development of blockchain-oriented ASIC chips, production of high-end crypto miners for Bitcoin and other cryptocurrencies, and Fintech software services. The Company mainly derives revenue from the sales of cryptocurrency mining machines and standardized computing equipment.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Share on Social Networks: